Health Care/Hospital

VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation

Empowering key ecosystem players to find each other easily and work together SINGAPORE, May 8, 2024 /PRNewswire/ -- VentureBlick announces the launch of Discovery, a groundbreaking networking platform designed to connect healthcare innovators, advisors, investors, distributors, partners, and serv...

2024-05-08 14:37 627

NSG BioLabs Fuels Biotech Innovation in Singapore and Southeast Asia Through Partnerships with EnterpriseSG and Merck, Alongside Investments from Celadon Partners and ClavystBio

* Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the startups have achieved nearlyUS$400 million funding in total alongside significant business milestones * NSG BioLabs' partnerships with EnterpriseSG and ...

2024-05-08 10:00 898

Everest Medicines Announces New Drug Application Approval of VELSIPITY® for Adults with Moderately to Severely Active Ulcerative Colitis in Macau

SHANGHAI, May 8, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative medicines and vaccines, announced today that the Pharmaceutical Administration ...

2024-05-08 08:05 879

Newly Published Data in JAMA Cardiology Demonstrates Favorable Long-term Effects of the Corvia Atrial Shunt in Heart Failure Patients

Two years of echocardiographic data affirm positive effects of atrial shunt therapy on heart structure and function TEWKSBURY, Mass., May 8, 2024 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced the publication in JAMA Cardi...

2024-05-08 06:17 803

YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer

GAITHERSBURG, Md., May 8, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disease...

2024-05-08 04:20 949

Santa J. Ono, University of Michigan President, Joins USJF Board

WASHINGTON, May 8, 2024 /PRNewswire/ -- Santa J. Ono, president of the University of Michigan, has joined the United States-Japan Foundation Board of Trustees. Ono, an accomplished medical researcher and leader in higher education across North America, is a second-generation Japanese American wh...

2024-05-08 04:00 826

Seragon Completes Pre-Clinical Study of Aging Intervention Candidate SRN-901

IRVINE, Calif., May 7, 2024 /PRNewswire/ -- Seragon Biosciences, Inc. today announced the completion of a pre-clinical study on its novel anti-aging candidate, SRN-901. This pivotal study, conducted in mice, was undertaken to evaluate the impact of SRN-901 on aging as well as various health marke...

2024-05-07 22:10 884

Imaging Endpoints Unveils New Initiative with Revolution Endpoints™, an Investment Subsidiary to Accelerate Innovation and Growth

SCOTTSDALE, Ariz., May 7, 2024 /PRNewswire/ -- Imaging Endpoints (IE), a global leader in Imaging CRO technologies and services, has announced the formation of a new subsidiary, Revolution Endpoints, focused on leveraging the Company's strong leadership and financial position to acquire synergist...

2024-05-07 21:00 836

Sciwind Biosciences and HK inno.N Corporation Announce Licensing and Partnership Agreement for Ecnoglutide Injection (XW003) in South Korea

HANGZHOU, China and SEOUL, South Korea, May 7, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical stage biopharmaceutical company focused on developing treatments for metabolic disease, and HK inno.N Corporation, a South Korean commercial stage pharmaceutical company (KOSDAQ: 195940),...

2024-05-07 15:00 860

Clarivate Introduces Epidemiology Intelligence™ for Precision Patient Population Analysis

Empowering biopharma with unified epidemiology, incidence and prevalence data alongside claims-based population insights, for precise market sizing and patient population analysis LONDON, May 7, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intellig...

2024-05-07 15:00 810

2024 World Brain Day Dedicated to Brain Health and Prevention

LONDON, May 7, 2024 /PRNewswire/ -- The World Federation of Neurology (WFN) is pleased to announce Brain Health and Prevention as the theme for the 2024 World Brain Day (WBD 2024), taking place onMonday, July 22. The goal is to raise critical awareness to prevent brain disease in all corners of t...

2024-05-07 14:45 342

Innovent Receives NMPA Breakthrough Therapy Designation for IBI343(Anti-Claudin18.2 ADC)as Monotherapy for Advanced Gastric Cancer

SAN FRANCISCO and SUZHOU, China, May 7, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ...

2024-05-07 08:12 1068

HTL Biotechnology, market leader in biopolymers, acquires the Modern Meadow's human recombinant collagen platform for beauty and biomedical applications

JAVENÉ, France, May 6, 2024 /PRNewswire/ -- HTL Biotechnology strengthens its position as a global leader in the production and development of pharmaceutical-grade biopolymers by acquiring the beauty and biomedical division of American company Modern Meadow (Nutley, NJ). Notably, this acquisitio...

2024-05-07 07:00 944

ThinkCyte Launches New Website and Showcases VisionSortTM at Global Events

TOKYO, May 7, 2024 /PRNewswire/ -- ThinkCyte today announced that it will be presenting at three major international scientific conferences in the first week of May and the launch of itsupdated website. The company will have a presence at the American Society for Immunology (AAI) fromMay 3rd to 7...

2024-05-06 23:25 988

21st.BIO unveils a new pilot plant facility to accelerate impact of biotech innovations globally

* Combining world-class industrially proven technology with fermentation capacity, 21st.BIO helps customers get to scale faster, in a risk-mitigated and cost-effective way. * Margrethe Vestager, Executive Vice President of the European Commission, was onsite to inaugurate the pilot facility, ...

2024-05-06 15:53 976

Global Fitness Giant Anytime Fitness Celebrates 25-Club Milestone in Indonesia

TANGERANG, Indonesia, May 6, 2024 /PRNewswire/ -- Anytime Fitness, the world's largest fitness franchise with over 5 million members throughout 5,500 clubs across 42 countries on all seven continents, announced its milestone 25th club in the health-crazed Indonesian market. Located at the bustlin...

2024-05-06 15:49 1249

Healthplex Expo, Natural & Nutraceutical Products China 2024 to Shine in Shanghai in June

SHANGHAI, April 30, 2024 /PRNewswire/ -- "Healthplex Expo 2024, Natural & Nutraceutical Products China 2024" (HNC), co-organized by CCCMHPIE and Sinoexpo Informa Markets, will be held during19-21 June 2024 at the National Exhibition and Convention Center (NECC)in Shanghai. HNC expo will be co-loc...

2024-05-06 13:29 1230

Dr. Sarah Salvilla to lead new FWD HealthyMe business

HONG KONG, May 6, 2024 /PRNewswire/ -- FWD Group Holdings Limited ("FWD Group" or "FWD") today announced the appointment of Dr.Sarah Salvilla as Group Chief Health Officer to lead a new health business unit, FWD HealthyMe.

2024-05-06 11:17 1164

Alphamab Oncology to Present Chinese Clinical Data of JSKN003 for the Treatment of HER2-expressing Solid Tumors for the First Time at the 2024 ASCO Annual Meeting

SUZHOU, China, May 6, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that data from the clinical study conducted inChina (JSKN003-102) of anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 for the treatment of HER2-expressing advanced solid tumors, will be presente...

2024-05-06 10:25 1868

Palm Oil Giant Musim Mas Pledges Third Tranche of S$5 million In Boost to Local Charities

Latest donation makes it S$16 million in 5 years as the Singapore-based company reaffirms commitment to improving lives SINGAPORE, May 6, 2024 /PRNewswire/ -- Palm oil giant Musim Mas Group has announced its latestS$5 million donation to selected local charities. This brings the group's total do...

2024-05-06 09:00 1229
12345 ... 554